Most recently, it has been identified that conolidine and the above derivatives act within the atypical chemokine receptor 3 (ACKR3. Expressed in related places as classical opioid receptors, it binds to your big selection of endogenous opioids. Compared with most opioid receptors, this receptor functions as being a scavenger and will not activate